Search Results - "de Vos, A. M."

Refine Results
  1. 1

    Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site by Heemelaar, J. C, Berkhout, T., Heestermans, A. A. C. M., Zant, J. C., de Vos, A. M. J., Verouden, N. J. W., Dirksen, M. T., van Ramshorst, J.

    “…Background/Purpose. We aimed to investigate the influence of the sampling site on the variability of ACT measurement. Activated clotting time (ACT) has been…”
    Get full text
    Journal Article
  2. 2

    Characteristics of chest pain in COVID-19 patients in the emergency department by Sinkeldam, M., Buenen, A. G., Celiker, E., van Diepen, M., de Vos, A. M.

    Published in Netherlands heart journal (01-11-2022)
    “…Introduction Patients with coronavirus disease 2019 (COVID-19) can present with chest pain. However, the characteristics of this chest pain are unknown. We…”
    Get full text
    Journal Article
  3. 3

    Nerve growth factor: structure and function by Wiesmann, C, de Vos, A M

    “…Neurotrophins are critical for the development and maintenance of the peripheral and central nervous system. These highly homologous, homodimeric growth…”
    Get full text
    Journal Article
  4. 4

    A quick and robust MHC typing method for free-ranging and captive primate species by de Groot, N., Stanbury, K., de Vos-Rouweler, A. J. M., de Groot, N. G., Poirier, N., Blancho, G., de Luna, C., Doxiadis, G. G. M., Bontrop, R. E.

    Published in Immunogenetics (New York) (01-04-2017)
    “…Gene products of the major histocompatibility complex (MHC) of human and non-human primates play a crucial role in adaptive immunity, and most of the relevant…”
    Get full text
    Journal Article
  5. 5

    Two-Amino Acid Molecular Switch in an Epithelial Morphogen That Regulates Binding to Two Distinct Receptors by Yan, Minhong, Wang, Li-Chong, Hymowitz, Sarah G., Schilbach, Sarah, Lee, James, Goddard, Audrey, de Vos, Abraham M., Gao, Wei-Qiang, Dixit, Vishva M.

    “…Ectodysplasin, a member of the tumor necrosis factor family, is encoded by the anhidrotic ectodermal dysplasia (EDA) gene. Mutations in EDA give rise to a…”
    Get full text
    Journal Article
  6. 6

    Convergent Solutions to Binding at a Protein-Protein Interface by DeLano, Warren L., Ultsch, Mark H., de Vos, Abraham M., Wells, James A.

    “…The hinge region on the Fc fragment of human immunoglobulin G interacts with at least four different natural protein scaffolds that bind at a common site…”
    Get full text
    Journal Article
  7. 7

    Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor by de Vos, Abraham M, Wiesmann, Christian, Ultsch, Mark H, Bass, Steven H

    Published in Nature (London) (09-09-1999)
    “…Nerve growth factor (NGF) is involved in a variety of processes involving signalling, such as cell differentiation and survival, growth cessation and apoptosis…”
    Get full text
    Journal Article
  8. 8

    Mutations of ovine and bovine placental lactogens change, in different ways, the biological activity mediated through homologous and heterologous lactogenic receptors by Helman, D, Herman, A, Paly, J, Livnah, O, Elkins, PA, de Vos, AM, Djiane, J, Gertler, A

    Published in Journal of endocrinology (01-04-2001)
    “…The biological activities of ovine (o) and bovine (b) placental lactogens (PLs) and their mutated analogues were compared using several binding and in vitro…”
    Get full text
    Journal Article
  9. 9

    How parents and physicians experience end-of-life decision-making for children with profound intellectual and multiple disabilities by Zaal-Schuller, I.H., Willems, D.L., Ewals, F.V.P.M., van Goudoever, J.B., de Vos, M.A.

    Published in Research in developmental disabilities (01-12-2016)
    “…•A long-lasting treatment relationship facilitates end-of-life decision-making.•Physicians underestimate parents’ readiness to discuss end-of-life…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Considering quality of life in end-of-life decisions for severely disabled children by Zaal-Schuller, I.H., Willems, D.L., Ewals, F.V.P.M., van Goudoever, J.B., de Vos, M.A.

    Published in Research in developmental disabilities (01-02-2018)
    “…End-of-life decisions (EoLDs) are very difficult to make. How parents and physicians incorporate quality of life (QoL) considerations into their end-of-life…”
    Get full text
    Journal Article
  13. 13

    Crystal Structure of Human Insulin-like Growth Factor-1:  Detergent Binding Inhibits Binding Protein Interactions by Vajdos, Felix F, Ultsch, Mark, Schaffer, Michelle L, Deshayes, Kurt D, Liu, Jun, Skelton, Nicholas J, de Vos, Abraham M

    Published in Biochemistry (Easton) (18-09-2001)
    “…Despite efforts spanning considerably more than a decade, a high-resolution view of the family of proteins known as insulin-like growth factors (IGFs) has…”
    Get full text
    Journal Article
  14. 14

    End-of-life decision-making for children with severe developmental disabilities: The parental perspective by Zaal-Schuller, I.H., de Vos, M.A., Ewals, F.V.P.M., van Goudoever, J.B., Willems, D.L.

    Published in Research in developmental disabilities (01-02-2016)
    “…•This review describes experiences of parents of disabled children regarding end-of-life decisions.•An electronic database search resulted in nine eligible…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Human Growth Hormone and Extracellular Domain of its Receptor: Crystal Structure of the Complex by de Vos, Abraham M., Ultsch, Mark, Kossiakoff, Anthony A.

    “…Binding of human growth hormone (hGH) to its receptor is required for regulation of normal human growth and development. Examination of the 2.8 angstrom…”
    Get full text
    Journal Article
  17. 17

    No postcopulatory selection against MHC‐homozygous offspring: Evidence from a pedigreed captive rhesus macaque colony by Sterck, E. H. M., Bontrop, R. E., Groot, N., Vos‐Rouweler, A. J. M., Doxiadis, G. G. M.

    Published in Molecular ecology (01-07-2017)
    “…The heterozygosity status of polymorphic elements of the immune system, such as the major histocompatibility complex (MHC), is known to increase the potential…”
    Get full text
    Journal Article
  18. 18

    Decision making in treatment of symptomatic severe aortic stenosis: a survey study in Dutch heart centres by van Beek-Peeters, J. J. A. M., van den Ende, Z., Faes, M. C., de Vos, A. J. B. M., van Geldorp, M. W. A., Van den Branden, B. J. L., van der Meer, B. J. M., Minkman, M. M. N.

    Published in Netherlands heart journal (01-09-2022)
    “…Aim To provide insight into the basic characteristics of decision making in the treatment of symptomatic severe aortic stenosis (SSAS) in Dutch heart centres…”
    Get full text
    Journal Article
  19. 19

    The X-ray structure of a growth hormone-prolactin receptor complex by Somers, William, Ultsch, Mark, De Vos, Abraham M, Kossiakoff, Anthony A

    Published in Nature (London) (01-12-1994)
    “…The human pituitary hormones, growth hormone (hGH) and prolactin (hPRL), regulate a large variety of physiological processes, among which are growth and…”
    Get full text
    Journal Article
  20. 20

    Involvement of nurses in end‐of‐life discussions for severely disabled children by Zaal‐Schuller, I. H., Willems, D. I., Ewals, F., Goudoever, J. B., Vos, M. A.

    “…Background In children with profound intellectual and multiple disabilities (PIMD), discussions about end‐of‐life decisions (EoLDs) are comparatively common…”
    Get full text
    Journal Article